Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 127 Records) |
Query Trace: Leukemia and IGHV[original query] |
---|
EXPRESSION OF LIPOPROTEIN LIPASE AND c-MYC ONCOGENE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AFFECTED BY THE CHORNOBYL ACCIDENT. Problemy radiatsiinoi medytsyny ta radiobiolohii 2020 12 25 421-429. Bilous N I, Abramenko I V, Chumak A A, Diagil I S, Martina Z |
Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3K? inhibitor therapy. Blood 2020 12 137 (20): 2817-2826. Mato Anthony R, Ghosh Nilanjan, Schuster Stephen J, Lamanna Nicole, Pagel John M, Flinn Ian W, Barrientos Jacqueline C, Rai Kanti R, Reeves James A, Cheson Bruce D, Barr Paul M, Kambhampati Suman, Lansigan Frederick, Pu Jeffrey J, Skarbnik Alan P, Roeker Lindsey, Fonseca Gustavo A, Sitlinger Andrea, Hamadeh Issam S, Dorsey Colleen, LaRatta Nicole, Weissbrot Hanna, Luning Prak Eline T, Tsao Patricia, Paskalis Dana, Sportelli Peter, Miskin Hari P, Weiss Michael S, Svoboda Jakub, Brander Danielle |
The signs of negative selection in IGHV framework regions are associated with worse overall survival of chronic lymphocytic leukemia patients. Leukemia research 2021 Aug 110 106686. Abramenko Iryna, Bilous Nadia, Chumak Anatoliy, Kryachok Iryna, Fedorenko Zoya, Martina Zoya, Dyagil Iry |
Association of lipoprotein lipase expression with TP53 gene polymorphisms in chronic lymphocytic leukemia cells. Experimental oncology 2021 9 43 (3): 224-228. Abramenko I, Bilous N, Chumak A, Dyagil I, Martina |
Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM). PloS one 2021 16 (9): e0257353. González-Rincón Julia, Garcia-Vela José A, Gómez Sagrario, Fernández-Cuevas Belén, Nova-Gurumeta Sara, Pérez-Sanz Nuria, Alcoceba Miguel, González Marcos, Anguita Eduardo, López-Jiménez Javier, González-Barca Eva, Yáñez Lucrecia, Pérez-Persona Ernesto, de la Serna Javier, Fernández-Zarzoso Miguel, Deben Guillermo, Peñalver Francisco J, Fernández María C, de Oteyza Jaime Pérez, Andreu M Ángeles, Ruíz-Guinaldo M Ángeles, Paz-Arias Raquel, García-Malo M Dolores, Recasens Valle, Collado Rosa, Córdoba Raúl, Navarro-Matilla Belén, Sánchez-Beato Margarita, García-Marco José |
Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options. Blood 2021 5 138 (25): 2670-2685. Malcikova Jitka, Pavlova Sarka, Kunt Vonkova Barbara, Radova Lenka, Plevova Karla, Kotaskova Jana, Pal Karol, Dvorackova Barbara, Zenatova Marcela, Hynst Jakub, Ondrouskova Eva, Panovska Anna, Brychtova Yvona, Zavacka Kristyna, Tichy Boris, Tom Nikola, Mayer Jiri, Doubek Michael, Pospisilova Sar |
Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patients. Haematologica 2021 Mar . Bloehdorn Johannes, Krzykalla Julia, Holzmann Karlheinz, Gerhardinger Andreas, Jebaraj Billy Michael Chelliah, Bahlo Jasmin, Humphrey Kathryn, Tausch Eugen, Robrecht Sandra, Mertens Daniel, Schneider Christof, Fischer Kirsten, Hallek Michael, Döhner Hartmut, Benner Axel, Stilgenbauer Steph |
THE EXPRESSION OF THE MAIN AND ALTERNATIVE TRANSCRIPT (SORL1 Delta2) OF THE SORL1 GENE IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS AFFECTED BY THE CHORNOBYL ACCIDENT. Problemy radiatsiinoi medytsyny ta radiobiolohii 2021 12 26 273-283. Abramenko I V, Bilous N I, Chumak A A, Diagil I S, Martina Z |
The Hydropathy Index of the HCDR3 Region of the B-Cell Receptor Identifies Two Subgroups of IGHV-Mutated Chronic Lymphocytic Leukemia Patients With Distinct Outcome. Frontiers in oncology 2021 11 723722. Rodríguez-Caballero Arancha, Fuentes Herrero Blanca, Oliva Ariza Guillermo, Criado Ignacio, Alcoceba Miguel, Prieto Carlos, Pérez Caro María, García-Montero Andrés C, González Díaz Marcos, Forconi Francesco, Sarmento-Ribeiro Ana Bela, Almeida Julia, Orfao Alber |
HELQ and EGR3 expression correlate with IGHV mutation status and prognosis in chronic lymphocytic leukemia. Journal of translational medicine 2021 1 19 (1): 42. Guo Chao, Gao Ya-Yue, Ju Qian-Qian, Zhang Chun-Xia, Gong Ming, Li Zhen-Li |
Clonal evolution in chronic lymphocytic leukemia is associated with an unmutated IGHV status and frequently leads to a combination of loss of TP53 and TP53 mutation. Molecular biology reports 2022 9 49 (12): 12247-12252. Bracher Susanne, Fuhrmann Irene, Jeromin Sabine, Nadarajah Niroshan, Kern Wolfgang, Haferlach Torsten, Haferlach Claudia, Stengel An |
Impact of the Types and Relative Quantities of IGHV Gene Mutations in Predicting Prognosis of Patients With Chronic Lymphocytic Leukemia. Frontiers in oncology 2022 7 12 897280. Kaufman Matthew, Yan Xiao-Jie, Li Wentian, Ghia Emanuela M, Langerak Anton W, Rassenti Laura Z, Belessi Chrysoula, Kay Neil E, Davi Frederic, Byrd John C, Pospisilova Sarka, Brown Jennifer R, Catherwood Mark, Davis Zadie, Oscier David, Montillo Marco, Trentin Livio, Rosenquist Richard, Ghia Paolo, Barrientos Jacqueline C, Kolitz Jonathan E, Allen Steven L, Rai Kanti R, Stamatopoulos Kostas, Kipps Thomas J, Neuberg Donna, Chiorazzi Nichol |
Genetic Testing at Diagnosis Has Prognostic Value in Patients with Chronic Lymphocytic Leukemia including at Early Stages. Diagnostics (Basel, Switzerland) 2022 7 12 (8): . Suárez-Cabrera Alexia, Fiallo-Suárez Dolly Viviana, Stuckey Ruth, Uroz-de la Iglesia Marta Luna, Florido Yanira, Lemes-Castellano Angelina, Perera-Álvarez Miguel Ángel, Luzardo-Henríquez Hugo, de la Nuez Haridian, Fernández-Caldas Paula, de la Iglesia Silvia, Gómez-Casares María Teresa, Bilbao-Sieyro Cristi |
Real-world Clinical Outcomes of First-Line Ibrutinib or Chemoimmunotherapy in Patients with Chronic Lymphocytic Leukemia by Risk Status. Advances in therapy 2022 5 39 (7): 3292-3307. Huang Qing, Deering Kathleen L, Harshaw Qing, Leslie Lori |
TP53-altered chronic lymphocytic leukemia treated with firstline Bruton's tyrosine kinase inhibitor-based therapy: A retrospective analysis. American journal of hematology 2022 May . Cherng Hua-Jay J, Khwaja Raamis, Kanagal-Shamanna Rashmi, Tang Guilin, Burger Jan, Thompson Philip, Ferrajoli Alessandra, Estrov Zeev, Sasaki Koji, Sampath Deepa, Wang Xuemei, Kantarjian Hagop, Keating Michael, Wierda William G, Jain Nit |
Landscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemia. Leukemia research 2022 4 116 106827. Jelloul Fatima Zahra, Yang Richard, Garces Sofia, Kanagal-Shamanna Rashmi, Ok Chi Y, Loghavi Sanam, Routbort Mark J, Zuo Zhuang, Yin C Cameron, Floyd Kristen, Bassett Roland L, Wierda William, Jain Nitin, Thompson Philip, Luthra Rajyalakshmi, Medeiros L Jeffrey, Patel Keyur |
STEREOTYPED CASES IN UKRAINIAN COHORT OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS DEPENDING ON THE IONIZING RADIATION EXPOSURE. Problemy radiatsiinoi medytsyny ta radiobiolohii 2022 12 27 307-323. Bilous N I, Abramenko I V, Chumak A A, Dyagil I S, Martina Z |
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia 2022 12 37 (2): 339-347. Mansouri Larry, Thorvaldsdottir Birna, Sutton Lesley-Ann, Karakatsoulis Georgios, Meggendorfer Manja, Parker Helen, Nadeu Ferran, Brieghel Christian, Laidou Stamatia, Moia Riccardo, Rossi Davide, Catherwood Mark, Kotaskova Jana, Delgado Julio, Rodríguez-Vicente Ana E, Benito Rocío, Rigolin Gian Matteo, Bonfiglio Silvia, Scarfo Lydia, Mattsson Mattias, Davis Zadie, Gogia Ajay, Rani Lata, Baliakas Panagiotis, Foroughi-Asl Hassan, Jylhä Cecilia, Skaftason Aron, Rapado Inmaculada, Miras Fatima, Martinez-Lopez Joaquín, de la Serna Javier, Rivas Jesús María Hernández, Thornton Patrick, Larráyoz María José, Calasanz María José, Fésüs Viktória, Mátrai Zoltán, Bödör Csaba, Smedby Karin E, Espinet Blanca, Puiggros Anna, Gupta Ritu, Bullinger Lars, Bosch Francesc, Tazón-Vega Bárbara, Baran-Marszak Fanny, Oscier David, Nguyen-Khac Florence, Zenz Thorsten, Terol Maria Jose, Cuneo Antonio, Hernández-Sánchez María, Pospisilova Sarka, Mills Ken, Gaidano Gianluca, Niemann Carsten U, Campo Elias, Strefford Jonathan C, Ghia Paolo, Stamatopoulos Kostas, Rosenquist Richa |
Distinct Immunogenetic Profiles of Chronic Lymphocytic Leukemia in Asia: A Taiwan Cooperative Oncology Group Registry Study. HemaSphere 2022 12 6 (12): e803. Yao Chi-Yuan, Agathangelidis Andreas, Chuang Shih-Sung, Tsou Hsiao-Hui, Feng Wei-Lien, Liu Ta-Chih, Chen Tsai-Yun, Yu Yuan-Bin, Yeh Su-Peng, Yao Ming, Wang Chuan-Cheng, Lin Johnson, Hwang Wen-Li, Gau Jyh-Pyng, Chou Wen-Chien, Chao Tsu-Yi, Lin Liang-In, Tien Hwei-Fang, Ghia Paolo, Wu Shang- |
Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait? European journal of haematology 2022 1 108 (5): 369-378. Brieghel Christian, Galle Veerle, Agius Rudi, da Cunha-Bang Caspar, Andersen Michael A, Vlummens Philip, Mattsson Mattias, Rosenquist Richard, Smedby Karin E, Herling Carmen D, Bahlo Jasmin, Hallek Michael, Lundgren Jens D, Offner Fritz, Niemann Carsten |
del(8p) and TNFRSF10B loss are associated with a poor prognosis and resistance to fludarabine in chronic lymphocytic leukemia. Leukemia 2023 9 . Ludovic Jondreville, Lea Dehgane, Cecile Doualle, Luce Smagghe, Beatrice Grange, Frederic Davi, Leticia K Lerner, Delphine Garnier, Clotilde Bravetti, Olivier Tournilhac, Damien Roos-Weil, Marouane Boubaya, Elise Chapiro, Santos A Susin, Florence Nguyen-Kh |
High-throughput Proteomics Identifies THEMIS2 as Independent Biomarker of Treatment-free Survival in Untreated CLL. HemaSphere 2023 9 7 (10): e951. Paul J Hengeveld, P Martijn Kolijn, Jeroen A A Demmers, Wouter Doff, Julie M N Dubois, Melissa Rijken, Jorn L J C Assmann, Lina van der Straten, Henk Jan Boiten, Kirsten J Gussinklo, Peter J M Valk, Laura M Faber, Peter E Westerweel, Arnon P Kater, Mark-David Levin, Anton W Langer |
A CAPTIVATEing Analysis for Higher-Risk CLL. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 6 OF1-OF2. Kerry A Roge |
Outcomes in Patients with High-Risk Features after Fixed-Duration Ibrutinib plus Venetoclax: Phase II CAPTIVATE Study in First-Line Chronic Lymphocytic Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 6 OF1-OF9. John N Allan, Ian W Flinn, Tanya Siddiqi, Paolo Ghia, Constantine S Tam, Thomas J Kipps, Paul M Barr, Anna Elinder Camburn, Alessandra Tedeschi, Xavier C Badoux, Ryan Jacobs, Bryone J Kuss, Livio Trentin, Cathy Zhou, Anita Szoke, Christopher Abbazio, William G Wier |
Subgroup-specific gene expression profiles and mixed epistasis in chronic lymphocytic leukemia. Haematologica 2023 5 . Almut Lütge, Junyan Lu, Jennifer Hüllein, Tatjana Walther, Leopold Sellner, Bian Wu, Richard Rosenquist, Christopher C Oakes, Sascha Dietrich, Wolfgang Huber, Thorsten Ze |
Characterization of clonal immunoglobulin heavy V-D-J gene rearrangements in Chinese patients with chronic lymphocytic leukemia: Clinical features and molecular profiles. Frontiers in oncology 2023 3 13 1120867. Deng Xinyue, Zhang Meilan, Wang Jiachen, Zhou Xiaoxi, Xiao M |
Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic Leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 11 OF1-OF8. Nitin Jain, Lisa J Croner, John N Allan, Tanya Siddiqi, Alessandra Tedeschi, Xavier C Badoux, Karl Eckert, Leo W K Cheung, Anwesha Mukherjee, James P Dean, Edith Szafer-Glusman, John F Seymo |
Evidence of somatic hypermutation in the antigen binding sites of patients with CLL harboring IGHV genes with 100% germline identity. Frontiers in oncology 2023 1 12 1079772. Sofou Electra, Zaragoza-Infante Laura, Pechlivanis Nikolaos, Karakatsoulis Georgios, Notopoulou Sofia, Stavroyianni Niki, Psomopoulos Fotis, Georgiou Elisavet, de Septenville Anne Langlois, Davi Frederic, Agathangelidis Andreas, Chatzidimitriou Anastasia, Stamatopoulos Kost |
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia 2023 1 37 (2): 504. Mansouri Larry, Thorvaldsdottir Birna, Sutton Lesley-Ann, Karakatsoulis Georgios, Meggendorfer Manja, Parker Helen, Nadeu Ferran, Brieghel Christian, Laidou Stamatia, Moia Riccardo, Rossi Davide, Catherwood Mark, Kotaskova Jana, Delgado Julio, Rodríguez-Vicente Ana E, Benito Rocío, Rigolin Gian Matteo, Bonfiglio Silvia, Scarfo Lydia, Mattsson Mattias, Davis Zadie, Gogia Ajay, Rani Lata, Baliakas Panagiotis, Foroughi-Asl Hassan, Jylhä Cecilia, Skaftason Aron, Rapado Inmaculada, Miras Fatima, Martinez-Lopez Joaquín, de la Serna Javier, Rivas Jesús María Hernández, Thornton Patrick, Larráyoz María José, Calasanz María José, Fésüs Viktória, Mátrai Zoltán, Bödör Csaba, Smedby Karin E, Espinet Blanca, Puiggros Anna, Gupta Ritu, Bullinger Lars, Bosch Francesc, Tazón-Vega Bárbara, Baran-Marszak Fanny, Oscier David, Nguyen-Khac Florence, Zenz Thorsten, Terol Maria Jose, Cuneo Antonio, Hernández-Sánchez María, Pospisilova Sarka, Mills Ken, Gaidano Gianluca, Niemann Carsten U, Campo Elias, Strefford Jonathan C, Ghia Paolo, Stamatopoulos Kostas, Rosenquist Richa |
[Biological characteristics and clinical significance of stereotyped B-cell receptor in chronic lymphocytic leukemia]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2024 4 45 (2): 197-202. T L Qiu, J Y Li, Y X |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: